Laza Medical has secured up to $160m in a Series B structured financing round to advance robotic imaging technology for transforming the cardiac catheterisation laboratory.
GE HealthCare led the investment round, alongside contributions from returning investors AMED, PA MedTech, and Unorthodox Ventures.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Laza Medical aims to address procedural complexity, operational constraints, and workflow demands during cardiovascular interventions through combined robotic guidance and AI.
The technology remains under active development and has not received regulatory clearance or approval for commercial distribution in any geographical jurisdiction.
GE HealthCare cardiovascular and interventional solutions CEO Jyoti Gera said: “The future of cardiac intervention must be one where access, consistency, and quality of care are no longer barriers to better outcomes.
“Integrating imaging modalities so they work seamlessly together has the potential to redefine the cath lab, enabling more efficient workflows today and paving the way for smarter,...